These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
554 related articles for article (PubMed ID: 17686091)
21. Atorvastatin treatment for men with lower urinary tract symptoms and benign prostatic enlargement. Mills IW; Crossland A; Patel A; Ramonas H Eur Urol; 2007 Aug; 52(2):503-9. PubMed ID: 17343981 [TBL] [Abstract][Full Text] [Related]
22. Prevalence of lower urinary tract symptoms in men aged 45-79 years: a population-based study of 40 000 Swedish men. Andersson SO; Rashidkhani B; Karlberg L; Wolk A; Johansson JE BJU Int; 2004 Aug; 94(3):327-31. PubMed ID: 15291861 [TBL] [Abstract][Full Text] [Related]
23. Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study. Fukuta F; Masumori N; Mori M; Tsukamoto T BJU Int; 2012 Oct; 110(7):1023-9. PubMed ID: 22233355 [TBL] [Abstract][Full Text] [Related]
24. The pathophysiology of lower urinary tract symptoms after brachytherapy for prostate cancer. Blaivas JG; Weiss JP; Jones M BJU Int; 2006 Dec; 98(6):1233-7; discussion 1237. PubMed ID: 17125481 [TBL] [Abstract][Full Text] [Related]
25. High rate of prostate symptoms among Ariaal men from Northern Kenya. Campbell B Prostate; 2005 Jan; 62(1):83-90. PubMed ID: 15389807 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of storage and voiding symptoms among men aged 40 years and older in a US population-based study: results from the Male Attitudes Regarding Sexual Health study. Glasser DB; Carson C; Kang JH; Laumann EO Int J Clin Pract; 2007 Aug; 61(8):1294-300. PubMed ID: 17627708 [TBL] [Abstract][Full Text] [Related]
27. Impact of lower urinary tract symptoms on discomfort in men aged between 50 and 80 years. Robert G; Descazeaud A; Azzouzi R; Saussine C; Haillot O; Dumonceau O; Ballereau C; Fourmarier M; Devonec M; Lukacs B; Delongchamps NB; Desgrandchamps F; de la Taille A Urol Int; 2010; 84(4):424-9. PubMed ID: 20339294 [TBL] [Abstract][Full Text] [Related]
28. [Comparison of self-estimation of disuric disorders gauged IPSS scale and qualities of lives QoL with self-estimation of sexual life gauged by IIEF-5 scale]. LipczyĆski W; Dobrowolska-Glazar B; Dobrowolski ZF Przegl Lek; 2012; 69(6):247-52. PubMed ID: 23094437 [TBL] [Abstract][Full Text] [Related]
29. Serum prostate-specific antigen as a predictor of prostate volume in the community: the Krimpen study. Bohnen AM; Groeneveld FP; Bosch JL Eur Urol; 2007 Jun; 51(6):1645-52; discussion 1652-3. PubMed ID: 17320271 [TBL] [Abstract][Full Text] [Related]
30. Examining lower urinary tract symptom constellations using cluster analysis. Coyne KS; Matza LS; Kopp ZS; Thompson C; Henry D; Irwin DE; Artibani W; Herschorn S; Milsom I BJU Int; 2008 May; 101(10):1267-73. PubMed ID: 18336611 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of symptomatic BPE among Malaysian men aged 50 and above attending screening during prostate health awareness campaign. Teh GC; Sahabudin RM; Lim TC; Chong WL; Woo S; Mohan M; Khairullah A; Abrams P Med J Malaysia; 2001 Jun; 56(2):186-95. PubMed ID: 11771079 [TBL] [Abstract][Full Text] [Related]
32. Relationship between lower urinary tract symptoms frequency assessed by the IPSS and bothersomeness (SPI) among men older than 50 years old. Perrin P; Marionneau N; Cucherat M; Taieb C Eur Urol; 2005 Oct; 48(4):601-7. PubMed ID: 16055260 [TBL] [Abstract][Full Text] [Related]
33. The benign prostatic hyperplasia registry and patient survey: study design, methods and patient baseline characteristics. Roehrborn CG; Nuckolls JG; Wei JT; Steers W; BJU Int; 2007 Oct; 100(4):813-9. PubMed ID: 17822462 [TBL] [Abstract][Full Text] [Related]
34. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting. O'Leary MP; Wei JT; Roehrborn CG; Miner M; BJU Int; 2008 Jun; 101(12):1531-5. PubMed ID: 18445080 [TBL] [Abstract][Full Text] [Related]
35. Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty. Seftel AD; Rosen RC; Rosenberg MT; Sadovsky R Int J Clin Pract; 2008 Apr; 62(4):614-22. PubMed ID: 18266709 [TBL] [Abstract][Full Text] [Related]
36. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Stief CG; Porst H; Neuser D; Beneke M; Ulbrich E Eur Urol; 2008 Jun; 53(6):1236-44. PubMed ID: 18281145 [TBL] [Abstract][Full Text] [Related]
37. The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studies. Robertson C; Link CL; Onel E; Mazzetta C; Keech M; Hobbs R; Fourcade R; Kiemeney L; Lee C; Boyle P; McKinlay JB BJU Int; 2007 Feb; 99(2):347-54. PubMed ID: 17313423 [TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of lower urinary tract symptoms and bother in both sexes. Terai A; Matsui Y; Ichioka K; Ohara H; Terada N; Yoshimura K Urology; 2004 Mar; 63(3):487-91. PubMed ID: 15028443 [TBL] [Abstract][Full Text] [Related]
39. The relation of lower urinary tract symptoms with life-style factors and objective measures of benign prostatic enlargement and obstruction: an Italian survey. Tubaro A; La Vecchia C; Eur Urol; 2004 Jun; 45(6):767-72. PubMed ID: 15149750 [TBL] [Abstract][Full Text] [Related]
40. [Prevalence of benign prostatic hyperplasia in general practice and practical approach of the Tunisian general practitioner (Prevapt study)]. Horchani A; Binous MY; Ben Hamida A; Sallami S; El Adbi H; Naji A Tunis Med; 2007 Aug; 85(8):619-24. PubMed ID: 18254279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]